These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34369120)

  • 1. Bell v Tavistock: Why the Assent Model Is Most Appropriate for Decisions Regarding Puberty Suppression for Transgender and Gender Diverse Youth.
    Notini L
    J Law Med; 2021 Mar; 28(3):632-644. PubMed ID: 34369120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Backwards-step for Gillick: Trans Children's Inability to Consent to Treatment for Gender Dysphoria-Quincy Bell & Mrs A v The Tavistock and Portman NHS Foundation Trust and Ors [2020] EWHC 3274 (Admin).
    Moreton KL
    Med Law Rev; 2021 Dec; 29(4):699-715. PubMed ID: 34212203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not just a tragic compromise: The positive case for adolescent access to puberty-blocking treatment.
    Wenner DM; George BR
    Bioethics; 2021 Nov; 35(9):925-931. PubMed ID: 34427939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "No One Stays Just on Blockers Forever": Clinicians' Divergent Views and Practices Regarding Puberty Suppression for Nonbinary Young People.
    Notini L; Pang KC; Telfer M; McDougall R
    J Adolesc Health; 2021 Jun; 68(6):1189-1196. PubMed ID: 33121900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consent Rights of Gender Diverse Children in Australia and the United Kingdom: Will the Court's Involvement End?
    Jacko G
    J Law Med; 2022 Dec; 29(4):1269-1287. PubMed ID: 36763031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puberty Assessment and Consideration of Gonadotropin-Releasing Hormone Agonists in Transgender and Gender-Diverse Youth.
    Lee JY
    Pediatr Ann; 2023 Dec; 52(12):e462-e466. PubMed ID: 38049185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuprolide Acetate for Puberty Suppression in Transgender and Gender Diverse Youth: A Comparison of Subcutaneous Eligard Versus Intramuscular Lupron.
    Eitel KB; Hodax JK; DiVall S; Kidd KM; Salehi P; Sequeira GM
    J Adolesc Health; 2023 Feb; 72(2):307-311. PubMed ID: 36404242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High court should not restrict access to puberty blockers for minors.
    Beattie C
    J Med Ethics; 2022 Jan; 48(1):71-76. PubMed ID: 33593872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender Dysphoria in children and young people: The implications for clinical staff of the Bell V's Tavistock Judicial Review and Appeal Ruling.
    Helyar S; Jackson L; Patrick L; Hill A; Ion R
    J Clin Nurs; 2022 May; 31(9-10):e11-e13. PubMed ID: 34888970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgender Dependent Adolescents in the U.S. Military Health Care System: Demographics, Treatments Sought, and Health Care Service Utilization.
    Van Donge N; Schvey NA; Roberts TA; Klein DA
    Mil Med; 2019 May; 184(5-6):e447-e454. PubMed ID: 30325452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgender Minors and the Commencement of Hormone Treatment for Gender Dysphoria: Is Recent English Case Law Likely to Influence the Australian Legal Position?
    Smith M
    J Law Med; 2022 Mar; 29(1):50-61. PubMed ID: 35362278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. This Wasn't a Split-Second Decision": An Empirical Ethical Analysis of Transgender Youth Capacity, Rights, and Authority to Consent to Hormone Therapy.
    Clark BA; Virani A
    J Bioeth Inq; 2021 Mar; 18(1):151-164. PubMed ID: 33502682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgender medicine - puberty suppression.
    Panagiotakopoulos L
    Rev Endocr Metab Disord; 2018 Sep; 19(3):221-225. PubMed ID: 30112593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thinking an ethics of gender exploration: Against delaying transition for transgender and gender creative youth.
    Ashley F
    Clin Child Psychol Psychiatry; 2019 Apr; 24(2):223-236. PubMed ID: 30968720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV prevention and HIV care among transgender and gender diverse youth: design and implementation of a multisite mixed-methods study protocol in the U.S.
    Jadwin-Cakmak L; Reisner SL; Hughto JMW; Salomon L; Martinez M; Popoff E; Rivera BA; Harper GW
    BMC Public Health; 2019 Nov; 19(1):1531. PubMed ID: 31730450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Puberty Suppression and Surgical Options for Transgender Youth.
    van de Grift TC; van Gelder ZJ; Mullender MG; Steensma TD; de Vries ALC; Bouman MB
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33106340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE REQUIREMENT FOR TRANS AND GENDER DIVERSE YOUTH TO SEEK COURT APPROVAL FOR THE COMMENCEMENT OF HORMONE TREATMENT: A COMPARISON OF AUSTRALIAN JURISPRUDENCE WITH THE ENGLISH DECISION IN BELL.
    Smith MK
    Med Law Rev; 2023 Feb; 31(1):47-82. PubMed ID: 35916645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providing Affirmative Care to Transgender and Gender Diverse Youth: Disparities, Interventions, and Outcomes.
    Call DC; Challa M; Telingator CJ
    Curr Psychiatry Rep; 2021 Apr; 23(6):33. PubMed ID: 33851310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Puberty Suppression for a Nonbinary Teenager.
    Pang KC; Notini L; McDougall R; Gillam L; Savulescu J; Wilkinson D; Clark BA; Olson-Kennedy J; Telfer MM; Lantos JD
    Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31974217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological Functioning in Transgender Adolescents Before and After Gender-Affirmative Care Compared With Cisgender General Population Peers.
    van der Miesen AIR; Steensma TD; de Vries ALC; Bos H; Popma A
    J Adolesc Health; 2020 Jun; 66(6):699-704. PubMed ID: 32273193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.